Fragmentation of therapeutic monoclonal antibodies represents a critical quality attribute. Here, we report a novel visible light-induced heavy chain fragmentation of IgG1 mediated by an Fe(III)-containing histidine (His) buffer. Based on non-reducing sodium dodecylsulfate–polyacrylamide gel electrophoresis and mass spectrometry analysis, IgG1 fragments with apparent molecular weights of ∼130, ∼110, and ∼22 kDa were detected in photo-irradiated samples and were mechanistically rationalized with an oxidative cleavage at Thr259. Specifically, the reactions are proposed to involve the generation of an intermediary alkoxyl radical, which undergoes β-cleavage to yield a glycyl radical. The latter either converts into Gly or adds oxygen and follo...
Protein biotherapeutics, especially monoclonal antibodies (mAbs), have been on the rise due to their...
The oxo-bridged diiron(III) complex $[\{Fe(L-his)(dpq)\}_2(\mu -O)]^{2+}$ having L-histidine (L-his)...
Protein pharmaceuticals, like monoclonal antibodies (mAbs), are sensitive to many degradation pathwa...
Immunoglobulin gamma (IgG) monoclonal antibodies (mAbs) are glycoproteins that have emerged as power...
The exposure of IgG1 in aqueous solution to light with λ = 254 nm or λ > 295 nm yields products cons...
The photoirradiation of a monoclonal antibody 1 (mAb1) at λ = 254 nm and λ<sub>max</sub> = 305 nm re...
Photostability conditions as prescribed by ICH guidelines induced highly reduction-resistant scrambl...
Antibody-dependent cell-mediated cytotoxicity (ADCC) is an effector function of immunoglobulins (IgG...
Ultrashort UV pulses at 258 nm with repetition rate of 10 kHz have been used to irradiate buffer sol...
Since the approval of the first monoclonal antibody (mAb) drug in 1986, mAbs have developed into a m...
Disulfide heterogeneity and other non-native crosslinks introduced during therapeutic antibody produ...
During the purification process, monoclonal antibodies may be exposed to parts of UV-C (200 to 290 n...
This account summarizes recent work on photo-induced side chain cleavage reactions of Tyr in IgG4-Fc...
The oxo-bridged diiron(III) complex [{Fe(L-his)(dpq)}<SUB>2</SUB>(μ-O)]<SUP>2+</SUP> having L-h...
We investigated the discoloration of a highly concentrated monoclonal antibody (mAbZ) in sodium acet...
Protein biotherapeutics, especially monoclonal antibodies (mAbs), have been on the rise due to their...
The oxo-bridged diiron(III) complex $[\{Fe(L-his)(dpq)\}_2(\mu -O)]^{2+}$ having L-histidine (L-his)...
Protein pharmaceuticals, like monoclonal antibodies (mAbs), are sensitive to many degradation pathwa...
Immunoglobulin gamma (IgG) monoclonal antibodies (mAbs) are glycoproteins that have emerged as power...
The exposure of IgG1 in aqueous solution to light with λ = 254 nm or λ > 295 nm yields products cons...
The photoirradiation of a monoclonal antibody 1 (mAb1) at λ = 254 nm and λ<sub>max</sub> = 305 nm re...
Photostability conditions as prescribed by ICH guidelines induced highly reduction-resistant scrambl...
Antibody-dependent cell-mediated cytotoxicity (ADCC) is an effector function of immunoglobulins (IgG...
Ultrashort UV pulses at 258 nm with repetition rate of 10 kHz have been used to irradiate buffer sol...
Since the approval of the first monoclonal antibody (mAb) drug in 1986, mAbs have developed into a m...
Disulfide heterogeneity and other non-native crosslinks introduced during therapeutic antibody produ...
During the purification process, monoclonal antibodies may be exposed to parts of UV-C (200 to 290 n...
This account summarizes recent work on photo-induced side chain cleavage reactions of Tyr in IgG4-Fc...
The oxo-bridged diiron(III) complex [{Fe(L-his)(dpq)}<SUB>2</SUB>(μ-O)]<SUP>2+</SUP> having L-h...
We investigated the discoloration of a highly concentrated monoclonal antibody (mAbZ) in sodium acet...
Protein biotherapeutics, especially monoclonal antibodies (mAbs), have been on the rise due to their...
The oxo-bridged diiron(III) complex $[\{Fe(L-his)(dpq)\}_2(\mu -O)]^{2+}$ having L-histidine (L-his)...
Protein pharmaceuticals, like monoclonal antibodies (mAbs), are sensitive to many degradation pathwa...